Search research articles
Contact Us
Filters
Showing results (41-50 of 70) with videos related to
Page
of 7
Sort By:
Journal of Oncology Practice
|
May 20, 2014
The ASCO Quality Training Program: designing and implementing a medical specialty society-based quality improvement training program
Joseph O Jacobson, Doris Quinn, Timothy Gilligan, et al.
Nature Reviews. Disease Primers
|
October 7, 2018
Testicular cancer
Liang Cheng, Peter Albers, Daniel M Berney, et al.
Clinical Genitourinary Cancer
|
February 12, 2018
Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor Inhibitors
Kriti Mittal, Lisa Derosa, Laurence Albiges, et al.
Clinical Genitourinary Cancer
|
September 15, 2016
Clinical Effect of Dose Escalation After Disease Progression in Patients With Metastatic Renal Cell Carcinoma
Moshe C Ornstein, Laura Wood, Paul Elson, et al.
Journal of Oncology Practice
|
February 20, 2014
High-priority topics for cancer quality measure development: results of the 2012 American Society of Clinical Oncology Collaborative Cancer Measure Summit
Michael J Hassett, Kristen K McNiff, Adam P Dicker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2016
Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
Matthew I Milowsky, R Bryan Rumble, Christopher M Booth, et al.
The Prostate
|
June 9, 2018
Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy
Pedro Barata, Hamid Emamekhoo, Prateek Mendiratta, et al.
Cancer
|
September 1, 2010
Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab
Jorge A Garcia, Thomas E Hutson, Paul Elson, et al.
Urologic Oncology
|
August 23, 2018
The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era
Yu-Wei Chen, Moshe C Ornstein, Laura S Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2025
The Art of the Art of Oncology
Mikkael A Sekeres, Gregory A Abel, Timothy Gilligan, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 70) with videos related to
Sort By:
Page
of 7
Journal of Oncology Practice
|
May 20, 2014
The ASCO Quality Training Program: designing and implementing a medical specialty society-based quality improvement training program
Joseph O Jacobson, Doris Quinn, Timothy Gilligan, et al.
Nature Reviews. Disease Primers
|
October 7, 2018
Testicular cancer
Liang Cheng, Peter Albers, Daniel M Berney, et al.
Clinical Genitourinary Cancer
|
February 12, 2018
Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor Inhibitors
Kriti Mittal, Lisa Derosa, Laurence Albiges, et al.
Clinical Genitourinary Cancer
|
September 15, 2016
Clinical Effect of Dose Escalation After Disease Progression in Patients With Metastatic Renal Cell Carcinoma
Moshe C Ornstein, Laura Wood, Paul Elson, et al.
Journal of Oncology Practice
|
February 20, 2014
High-priority topics for cancer quality measure development: results of the 2012 American Society of Clinical Oncology Collaborative Cancer Measure Summit
Michael J Hassett, Kristen K McNiff, Adam P Dicker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2016
Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
Matthew I Milowsky, R Bryan Rumble, Christopher M Booth, et al.
The Prostate
|
June 9, 2018
Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy
Pedro Barata, Hamid Emamekhoo, Prateek Mendiratta, et al.
Cancer
|
September 1, 2010
Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab
Jorge A Garcia, Thomas E Hutson, Paul Elson, et al.
Urologic Oncology
|
August 23, 2018
The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era
Yu-Wei Chen, Moshe C Ornstein, Laura S Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2025
The Art of the Art of Oncology
Mikkael A Sekeres, Gregory A Abel, Timothy Gilligan, et al.
Page
of 7